Home sunrisefpau Novo Nordisk is the biggest loser in the weight-loss duopoly Novo Nordisk is the biggest loser in the weight-loss duopoly Author - Financial Adviser Melbourne February 04, 2026 0 The Danish group’s share of the global GLP-1 market is shrinking, while Eli Lilly’s products are gaining ground International homepage Tags sunrisefpau Facebook Twitter Whatsapp Newer Older
